Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ascendis Pharma A/S (NASDAQ: ASND)
ASND Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-19.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
33.80%
ASND Stock Analysis
ASND
PE Ratio:
25.5
ASND
PEG Ratio:
-1.2
ASND
Forward EPS Growth (12 month):
-20.70%
ASND
PS Ratio:
13.5
ASND
PSG Ratio:
0.3
ASND
Forward Revenue Growth (12 month):
44.20%
ASND Articles
No data was found